226 related articles for article (PubMed ID: 26957489)
1. A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.
Vasquez M; Gasparis AP;
Phlebology; 2017 May; 32(4):272-281. PubMed ID: 26957489
[TBL] [Abstract][Full Text] [Related]
2. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
Todd KL; Wright DI;
Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
Gibson K; Kabnick L;
Phlebology; 2017 Apr; 32(3):185-193. PubMed ID: 27013511
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
King JT; O'Byrne M; Vasquez M; Wright D;
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
[TBL] [Abstract][Full Text] [Related]
5. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).
Todd KL; Wright DI;
J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):258-264.e1. PubMed ID: 26992303
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial of antithrombotic strategies following great saphenous vein ablation using injectable polidocanol endovenous microfoam (Varithena).
Yang J; Chung S; Srivatsa S
J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):488-497.e4. PubMed ID: 36592692
[TBL] [Abstract][Full Text] [Related]
7. Results of polidocanol endovenous microfoam in clinical practice.
Kim PS; Elias S; Gasparis A; Labropoulos N
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):122-127. PubMed ID: 32353594
[TBL] [Abstract][Full Text] [Related]
8. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes.
Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K;
J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174
[TBL] [Abstract][Full Text] [Related]
9. Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series.
Davis PE; Phillips J; Kolluri R
Ann Vasc Surg; 2018 Oct; 52():176-182. PubMed ID: 29772321
[TBL] [Abstract][Full Text] [Related]
10. Treatment of superficial venous insufficiency in a large patient cohort with retrograde administration of ultrasound-guided polidocanol endovenous microfoam versus endovenous laser ablation.
Deak ST
J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):999-1006.e2. PubMed ID: 34958977
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
Jimenez JC; Lawrence PF; Woo K; Chun TT; Farley SM; Rigberg DA; Baril DT; Derubertis BG
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):904-909. PubMed ID: 33248297
[TBL] [Abstract][Full Text] [Related]
12. Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency.
Deak ST
J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):477-484. PubMed ID: 29909854
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of non-compounded polidocanol 1% endovenous microfoam (Varithena) ablation versus endovenous thermal ablation utilizing a systematic review and network meta-analysis.
Kabnick LS; Jimenez JC; Coogan SM; Gache L; Frame D; Gunnarsson C; Ozsvath K
J Vasc Surg Venous Lymphat Disord; 2024 Apr; ():101896. PubMed ID: 38679141
[TBL] [Abstract][Full Text] [Related]
14. Clarivein® mechano-chemical ablation an interim analysis of a randomized controlled trial dose-finding study.
Lam YL; Toonder IM; Wittens CH
Phlebology; 2016 Apr; 31(3):170-6. PubMed ID: 26249150
[TBL] [Abstract][Full Text] [Related]
15. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
[TBL] [Abstract][Full Text] [Related]
17. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
Gonzalez-Zeh R; Armisen R; Barahona S
J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
[TBL] [Abstract][Full Text] [Related]
18. Increased body mass index and vein diameter are associated with incomplete target vein closure following microfoam ablation of incompetent saphenous veins.
Talutis SD; Chin AL; Lawrence PF; Woo K; Farley SM; Duong W; Jimenez JC
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101690. PubMed ID: 37788744
[TBL] [Abstract][Full Text] [Related]
19. Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam.
Lal BK; Mallick R; Wright D
Phlebology; 2017 Jun; 32(5):342-354. PubMed ID: 28114848
[TBL] [Abstract][Full Text] [Related]
20. Endovenous laser ablation with and without high ligation compared to high ligation and stripping for treatment of great saphenous varicose veins: Results of a multicentre randomised controlled trial with up to 6 years follow-up.
Flessenkämper I; Hartmann M; Hartmann K; Stenger D; Roll S
Phlebology; 2016 Feb; 31(1):23-33. PubMed ID: 25342648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
